Search research articles
Contact Us
Filters
Showing results (41-50 of 330) with videos related to
Page
of 33
Sort By:
Blood
|
November 3, 2009
Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?
Susan Branford, Junia V Melo, Timothy P Hughes
Leukemia
|
November 11, 1999
Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia
S Bose, J M Goldman, J V Melo
Environmental Technology
|
August 15, 2003
Flotation techniques for oily water treatment
M V Melo, G L Sant'anna, G Massarani
Leukemia
|
September 17, 2010
Do we have to kill the last CML cell?
D M Ross, T P Hughes, J V Melo
Acta Haematologica
|
January 1, 1987
Splenectomy in advanced chronic lymphocytic leukaemia
G Gallhofer, J V Melo, J Spencer, et al.
Revista Portuguesa De Pneumologia
|
September 8, 2016
Silicosis, tuberculosis time bomb?
V Melo, L Baía, A Rita Gaio, et al.
European Journal of Haematology
|
September 21, 2000
Ex vivo expansion and characterisation of CD34+ cells derived from chronic myeloid leukaemia bone marrow and peripheral blood, and from normal bone marrow and mobilised peripheral blood
M I Garin, J F Apperley, J V Melo
Blood
|
November 9, 2000
The molecular biology of chronic myeloid leukemia
M W Deininger, J M Goldman, J V Melo
Hematology. American Society of Hematology. Education Program
|
November 25, 2003
Chronic myeloid leukemia
Junia V Melo, Timothy P Hughes, Jane F Apperley
Journal of Helminthology
|
June 18, 2019
Description, molecular characterization and life cycle of <i>Serpentirhabdias mussuranae</i> n. sp. (Nematoda: Rhabdiasidae) from <i>Clelia clelia</i> (Reptilia: Colubroidea) in Brazil
Y Kuzmin, V V Tkach, F T V Melo
Page
of 33
Search research articles
Search
Showing results (41-50 of 330) with videos related to
Sort By:
Page
of 33
Blood
|
November 3, 2009
Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?
Susan Branford, Junia V Melo, Timothy P Hughes
Leukemia
|
November 11, 1999
Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia
S Bose, J M Goldman, J V Melo
Environmental Technology
|
August 15, 2003
Flotation techniques for oily water treatment
M V Melo, G L Sant'anna, G Massarani
Leukemia
|
September 17, 2010
Do we have to kill the last CML cell?
D M Ross, T P Hughes, J V Melo
Acta Haematologica
|
January 1, 1987
Splenectomy in advanced chronic lymphocytic leukaemia
G Gallhofer, J V Melo, J Spencer, et al.
Revista Portuguesa De Pneumologia
|
September 8, 2016
Silicosis, tuberculosis time bomb?
V Melo, L Baía, A Rita Gaio, et al.
European Journal of Haematology
|
September 21, 2000
Ex vivo expansion and characterisation of CD34+ cells derived from chronic myeloid leukaemia bone marrow and peripheral blood, and from normal bone marrow and mobilised peripheral blood
M I Garin, J F Apperley, J V Melo
Blood
|
November 9, 2000
The molecular biology of chronic myeloid leukemia
M W Deininger, J M Goldman, J V Melo
Hematology. American Society of Hematology. Education Program
|
November 25, 2003
Chronic myeloid leukemia
Junia V Melo, Timothy P Hughes, Jane F Apperley
Journal of Helminthology
|
June 18, 2019
Description, molecular characterization and life cycle of <i>Serpentirhabdias mussuranae</i> n. sp. (Nematoda: Rhabdiasidae) from <i>Clelia clelia</i> (Reptilia: Colubroidea) in Brazil
Y Kuzmin, V V Tkach, F T V Melo
Page
of 33